The complainant was unable to provide the suspect device lot number.Therefore, the expiration and device manufacture dates are unknown.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental mdr will be filed.
|
It was reported to boston scientific corporation that spaceoar vue was implanted during a spaceoar vue placement procedure performed on (b)(6) 2021.It was reported that, the patient was given 650mg tylenol and 1mg xanax one hour prior to the procedure.While the patient was in recovery following an uneventful and successful spaceoar vue implant, the patient developed an extensive rash on his torso.He also experienced nausea, dry heaves and itching on his lower back progressing to upper back and down thighs.The skin on the back and legs was bright pink with small area of hives.The patient also felt dizziness and passed out approximately 30 to 60 seconds a couple of times.The patient was transferred to a gurney.Emergency medical technician (emt) arrived at 5:00 and patient was assessed and taken to cottage emergency room.The patient was treated with zofran 8mg (odt) and oxygen was also administered prior to being moved to the emergency room.The patient was reported to have fully recovered.
|